hypericin has been researched along with l 663536 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brezáni, P; Fedorocko, P; Hofmanová, J; Horváth, V; Kleban, J; Kozubík, A; Mikes, J; Sacková, V; Szilárdiová, B | 1 |
Fedorocko, P; Hofmanová, J; Horváth, V; Kleban, J; Kozubík, A; Mikes, J; Sacková, V | 1 |
Fedoročko, P; Jendželovská, Z; Jendželovský, R; Kovaľ, J; Kuchárová, B; Mikeš, J; Mikešová, L; Vargová, J | 1 |
3 other study(ies) available for hypericin and l 663536
Article | Year |
---|---|
Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
Topics: Anthracenes; Apoptosis; Bromodeoxyuridine; Cell Cycle; DNA Replication; Dose-Response Relationship, Drug; HT29 Cells; Humans; Hydrolysis; Indoles; Lipoxygenase Inhibitors; Perylene; Photochemotherapy; Photosensitizing Agents; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species | 2006 |
Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
Topics: Anthracenes; Apoptosis; Cell Cycle; Colonic Neoplasms; Drug Synergism; HT29 Cells; Humans; Indoles; Lipoxygenase Inhibitors; Perylene; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Signal Transduction | 2008 |
Potentiation of hypericin-mediated photodynamic therapy cytotoxicity by MK-886: focus on ABC transporters, GDF-15 and redox status.
Topics: Anthracenes; ATP-Binding Cassette Transporters; Caspase 3; Cell Death; Cell Line, Tumor; Drug Synergism; Glutathione; Growth Differentiation Factor 15; Humans; Indoles; Membrane Potential, Mitochondrial; Neoplasms; Oxidation-Reduction; Perylene; Photochemotherapy; Photosensitizing Agents; RNA, Small Interfering | 2015 |